{"id":"W2909436531","doi":"10.2217/cer-2018-0073","title":"A cost–utility analysis of dulaglutide versus insulin glargine as third-line therapy for Type 2 diabetes in Canada","year":2019,"lang":"en","type":"article","venue":"Journal of Comparative Effectiveness Research","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"","keywords":"Medicine; Insulin glargine; Dulaglutide; Type 2 diabetes; Diabetes mellitus; Internal medicine; Insulin; Exenatide; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00267214,0.0001590423,0.001218033,0.0008987249,0.00003710423,0.00001446052,0.0001862271,0.0000445351,0.0001266044],"category_scores_gemma":[0.000308284,0.0001157702,0.000219431,0.001912316,0.00007911252,0.000111171,0.00005212449,0.0003365557,0.000005628061],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008712355,"about_ca_system_score_gemma":0.001418473,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_topic_score_codex":0.02426006,"about_ca_topic_score_gemma":0.04829093,"domain_scores_codex":[0.9974133,0.0006977532,0.000472781,0.0002114965,0.0008348213,0.0003698789],"domain_scores_gemma":[0.9946025,0.003270037,0.000226325,0.000257719,0.00151305,0.0001303787],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.03967309,0.001303046,0.9311917,0.0003393936,0.009177423,0.00003691881,0.0003287312,0.003467518,0.006445391,0.0002807651,0.0003222367,0.007433753],"study_design_scores_gemma":[0.01343612,0.006376534,0.9311091,0.0002447685,0.0004097506,4.295356e-7,0.0004650815,0.01073881,0.03534467,0.0001402578,0.001632392,0.0001021025],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.995166,0.001870753,0.00004689035,0.0001495025,0.0002167502,0.001804838,0.000015443,0.000002789176,0.0007270483],"genre_scores_gemma":[0.9994935,0.0002025948,0.00008604382,0.00001817883,0.00003721516,0.00005132173,0.00002513722,0.00001040074,0.00007557518],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.02889928,"threshold_uncertainty_score":0.9822375,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1614136600299384,"score_gpt":0.457361692122425,"score_spread":0.2959480320924865,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}